Cargando…
Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis
Currently, 15 randomized controlled trials (RCTs) have been designed to investigate whether neoadjuvant therapy (NAT) benefits patients with resectable pancreatic adenocarcinoma (R-PA) compared to surgery alone. Five of them have acquired results so far; however, corresponding conclusions have not b...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611436/ https://www.ncbi.nlm.nih.gov/pubmed/36310705 http://dx.doi.org/10.4251/wjgo.v14.i10.1903 |